Expression of ras p21 in the stromal cells of human neoplastic endometrium

European Journal of Gynaecological Oncology

Volumn 19, Issue 3, 1998, Pages 308-311

  Miturski, R ^a   Semczuk, A ^a   Jakowicki, J A ^a  

^a MEDICAL UNIVERSITY OF LUBLIN   (Poland)

Author keywords

Endometrial carcinoma; Immunohistochemistry; ras p21; Stromal cells

Indexed keywords

PROTEIN P21; RAS PROTEIN;

ADULT; AGED; ARTICLE; CANCER STAGING; CARCINOSARCOMA; CLINICAL ARTICLE; ENDOMETRIUM; ENDOMETRIUM CARCINOMA; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MYOMETRIUM; PROTEIN EXPRESSION; STROMA CELL;

AGED; CARCINOMA; CARCINOSARCOMA; ENDOMETRIAL NEOPLASMS; ENDOMETRIUM; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; PROTO-ONCOGENE PROTEINS P21(RAS);

EID: 0031921745     PISSN: 03922936     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Barbacid M.: "ras genes", Ann. Rev. Biochem., 1987, 56, 776.
2. Boguski S. M., McCormick F.: "Proteins regulating ras and its relatives". Nature, 1993, 366, 643.
3. Bos L. J.: "p21 ras: an oncoprotein functioning in growth factor-induced signal transduction". Eur J. Cancer, 1995, 31A, 1051.
4. Feig A L.: "The many roads that lead to ras" Science, 1993, 260, 767.
5. Waldmann V., Rabes H. M.: "What's new in ras genes? Psysiological role of ras genes in signal transduction and significance of ras gene activation in tumorigenesis" Path. Res. Pract., 1996, 192, 883.
6. Medema R., Bos L. J.: "The role of p21 ras in receptor tyrosine kinase signaling". Crit. Rev. Oncogenesis, 1993, 4, 615.
7. Prendergast C. G., Gibbs B. J.: "Ras regulatory interactions: novel targets for anti-cancer intervention?" BioEssays, 1994, 16, 187.
8. Gulbis B., Galand P.: "Immunodetection of the p21-ras products in human normal and preneoplastic tissues and solid tumors: a review". Hum. Pathol., 1993, 24, 1271.
9. Konishi N., Enomoto T., Buzard G., Ohshima M., Ward M. J., Rice M. J.: "K-ras activation and ras p21 expression in latent prostatic carcinoma in Japanese men". Cancer, 1992, 69, 2293.
10. Spandidos D. A., Liloglou T., Arvanitis D., Gourtsoyannis N. C.: "ras gene activation in human small intestinal tumors". Int. J. Oncol., 1993, 2, 513.
11. Matsukuma S., Suda K.: "Small pancreatic tubular adenocarcinomas: clinicopathological analysis with immunohistochemical and histochemical evaluation". Pathol. Int., 1996, 46, 581.
12. Yaginuma Y., Yamashita K., Kuzumaki N., Fujita M., Shimizu T. "ras oncogene product p21 expression and prognosis of human ovarian tumors". Gynecol. Oncol., 1992, 46, 45.
13. Scambia G, Catozzi L., Panici P. B. et al.: "Expression of ras oncogene product p21 in normal and neoplastic ovarian tissues: correlation with histopathologic features and receptors for estrogen, progesterone, and epidermal growth factor". Am. J. Obstet. Gynecol., 1993, 168, 71.
14. Gadducci A., Ciancia E. M., Campani D. et al.: "Immunohistochemical detection of p185 product, p21 product, and proliferating cell nuclear antigen (PCNA) in formalin-fixed, paraffin-embedded tissues from ovarian carcinomas. Preliminary data". Eur. J. Gynaecol. Oncol., 1994, 15, 359.
15. Kuwashima Y., Shisa H., Uehara T. et al.: "Immunohistochemical detection of ras p21 oncoprotein in undifferentiated and well-differentiated epithelial carcinomas of the human ovary". Anticancer Res., 1995, 15, 2847.
16. Hayashi Y., Hachisuga T., Iwasaka T., Fukuda K., Okuma Y., Yokoyama M., Sugimori H.: "Expression of ras oncogene product and EGF receptor in cervical squamous cell carcinomas and its relationship to lymph node involvement". Gynecol. Oncol., 1991, 40, 147.
17. Bar J. K., Markowska J., Harloźińska A. et al.: "Relation between infection with human papilloma viruses and expression of p21 and p53 oncoproteins in patients with cancer of the uterine cervix". Eur. J. Gynaecol. Oncol., 1996, 17, 283.
18. Lee J. H., Lee S. K., Yang M. H., Ahmed M. M., Mohiuddin M., Lee E. Y.: "Expression and mutation of H-ras in uterine cervical cancer". Gynecol. Oncol., 1996, 62, 49.
19. Agnantis N. J., Spandidos D. A., Mahera H. et al. "Immunohistochemical study of ras oncogene expression in endometrial and cervical human lesions". Eur. J. Gynaecol. Oncol., 1988, 9, 360.
20. Long A. C , O' Brien J. T., Sanders M. M., Bard S. D., Qiurk G. J.: "ras oncogene is expressed in adenocarcinoma of the endometrium". Am J Obstet. Gynecol., 1988, 159, 1512.
21. Yaginuma Y., Fujita M., Saitoh S. et al.: "Immunohistochemical analysis of ras oncogene product p21 in human endometrial carcinoma". Acta Histochem., 1993, 95, 23.
22. Yaginuma Y., Ishikawa M.: "ras p21 expression in human endometrial carcinoma". Int. J. Gynecol. Obstet., 1993, 42, 52.
23. Scambia G., Catozzi L., Benedetti-Panici P. et al.: "Expression of ras p21 oncoprotein in normal and neoplastic human endometrium" Gynecol. Oncol., 1993, 50, 339.
24. Semczuk A., Miturski R., Baranowski W., Jakowicki J. A.: "ras p21 immunohistochemical detection in human endometrial carcinomas", Gynecol. Obstet. Invest., 1997, 44, 132.
25. Scully E. R., Bonfiglio A. T., Kurman J. R., Silverberg G. S., Wilkinson J. E.: "Histological typing of female genital tract tumors". Springer-Verlag, Berlin. Heidelberg, New York, 1992.
26. FIGO Stages-1988 Revision, Gynecol. Oncol., 1989, 35, 125.
27. Miturski R., Semczuk A., Jakowicki J. A. "Simultaneous expression of the ras p21 and p53 proteins in human endometrial carcinomas". Acta Histochem., 1996, 98, 411.
28. Semczuk A., Miturski R., Tomaszewski J., Putowski L. T., Jakowicki J. A.: "Assessment of p53 protein expression in human endometrial carcinomas". Gin. Pol., 1996, 67 (Suppl. 6), 119.
29. Nyholm H. C. J., Nielsen A. L., Lyndrup J., Norup P., Thorpe S. M.: "Biochemical and immunohistochemical estrogen and progesterone receptors in adenomatous hyperplasia and endometrial carcinoma: correlation with stage and other clinicopathologic features". Am. J. Obstet. Gynecol., 1992, 167, 1334.
30. Furth E. M., Aldrich H. T., Cordon-Cardo C.: "Expression of ras proto-oncogene proteins in normal human tissues". Oncogene, 1987, 1, 47.
31. Odom D. L., Barrett M. J., Pantazis G. C., Stoddard D. L., Mcdonough G. P.: "Immunohistochemical study of ras and myc proto-oncogene polypeptide expression in the human menstrual cycle". Am. J. Obstet. Gynecol., 1989, 161, 1663.
32. Bohme M., Lottge M., Schmidt D., Rose I., Weise W., Morenz J.: "Lymphohistiocytic infiltration of endometrial adenocarcinoma". Zentralbl. Gynecol., 1995, 177, 247.